Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Beta Bionics, Inc. - Common Stock
(NQ:
BBNX
)
20.59
-0.92 (-4.28%)
Streaming Delayed Price
Updated: 10:26 AM EDT, Sep 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
164,193
Open
21.50
Bid (Size)
20.55 (200)
Ask (Size)
20.68 (100)
Prev. Close
21.51
Today's Range
20.57 - 21.70
52wk Range
8.800 - 32.71
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026
Today 9:30 EDT
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Kaplan Fox & Kilsheimer LLP Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before November 3, 2026
September 25, 2026
NEW YORK, NY - September 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ:...
Via
NewMediaWire
Topics
Lawsuit
Performance
YTD
-29.6%
-29.6%
1 Month
+4.4%
+4.4%
3 Month
+21.1%
+21.1%
6 Month
+108.8%
+108.8%
1 Year
+3.7%
+3.7%
More News
Read More
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors with Losses to Contact the Firm Before November 3, 2026
September 25, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
September 25, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) and Lead Plaintiff Deadline on November 3, 2026
September 24, 2026
Via
NewMediaWire
Topics
Lawsuit
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
September 24, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
Kaplan Fox Class Action Reminder: Beta Bionics, Inc. (NASDAQ: BBNX) Lead Plaintiff Deadline is November 3, 2026
September 24, 2026
Via
NewMediaWire
Topics
Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)
September 24, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) is November 3, 2026
September 23, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Pending Securities Class Action – Deadline is November 3, 2026
September 23, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Kaplan Fox Deadline Alert: Beta Bionics, Inc. (NASDAQ: BBNX) Investors Have Until November 3, 2026 to Seek a Lead Plaintiff Role
September 22, 2026
Via
NewMediaWire
Topics
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
September 22, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
September 22, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline
September 22, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026
September 22, 2026
Via
NewMediaWire
Topics
Lawsuit
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
September 22, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is
September 22, 2026
From
Grabar Law Office
Via
GlobeNewswire
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
September 22, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026
September 21, 2026
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026
September 21, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Kaplan Fox Continues to Remind Beta Bionics, Inc. (NASDAQ: BBNX) Investors of the Lead Plaintiff Deadline on November 3, 2026
September 18, 2026
Via
NewMediaWire
Topics
Lawsuit
Robbins LLP Urges BBNX Stockholders Who Lost Money Investing in Beta Bionics, Inc. to Contact the Firm for Information About Leading the Class Action
September 18, 2026
From
Robbins LLP
Via
Business Wire
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) with Significant Losses to Seek a Leadership Role Before November 3, 2026
September 18, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 3, 2026 Against Beta Bionics, Inc. (NASDAQ: BBNX)
September 17, 2026
Via
NewMediaWire
Topics
Lawsuit
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
September 17, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Beta Bionics, Inc. - Common Stock publicly traded?
Yes, Beta Bionics, Inc. - Common Stock is publicly traded.
What exchange does Beta Bionics, Inc. - Common Stock trade on?
Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Beta Bionics, Inc. - Common Stock?
The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market
What is the current price of Beta Bionics, Inc. - Common Stock?
The current price of Beta Bionics, Inc. - Common Stock is 20.59
When was Beta Bionics, Inc. - Common Stock last traded?
The last trade of Beta Bionics, Inc. - Common Stock was at 09/28/26 10:26 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.